TRVI icon

Trevi Therapeutics

17 hedge funds and large institutions have $28.1M invested in Trevi Therapeutics in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.

Holders
17
Holders Change
-2
Holders Change %
-10.53%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
3
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
NMC
1
NEA Management Company
Maryland
$13.4M 5,940,796
TGHSA
2
TPG Group Holdings (SBS) Advisors
Texas
$10.9M 4,824,883
OFM
3
Omega Fund Management
Massachusetts
$2.84M 1,263,408
Vanguard Group
4
Vanguard Group
Pennsylvania
$300K 133,215
Renaissance Technologies
5
Renaissance Technologies
New York
$208K 92,600 -29,249 -24%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$110K 49,077
BlackRock
7
BlackRock
New York
$99K 44,180 +11,786 +36%
WA
8
WealthTrust Axiom
Pennsylvania
$88K 39,500 +1,000 +3%
BCM
9
Bridgeway Capital Management
Texas
$78K 34,600 -75,000 -68%
AIMCA
10
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$56K 25,000 +25,000 New
Northern Trust
11
Northern Trust
Illinois
$26K 11,414
LPL Financial
12
LPL Financial
California
$23K 10,000
TRCT
13
Tower Research Capital (TRC)
New York
$10K 4,187 +2,950 +238%
First Manhattan
14
First Manhattan
New York
$7K 3,500 +1,600 +84%
UBS Group
15
UBS Group
Switzerland
$5K 2,137 -241 -10%
Fidelity Investments
16
Fidelity Investments
Massachusetts
-576,500 Closed
Citadel Advisors
17
Citadel Advisors
Florida
-10,617 Closed
Morgan Stanley
18
Morgan Stanley
New York
-1,000 Closed
Bank of America
19
Bank of America
North Carolina
-16 Closed
CFGS
20
Concourse Financial Group Securities
Alabama
Wells Fargo
21
Wells Fargo
California
$0 33 +9 +38%
Barclays
22
Barclays
United Kingdom
$0 100 +100 New